Amphastar is continuing in its shift towards a more proprietary portfolio through the development of new products with different delivery systems, as discussed in a fireside chat at this year’s Jefferies Healthcare Conference – which took place in London in late November – in which members of Amphastar’s management focused on the company’s latest results and recent efforts.
Attended by Amphastar’s executive vice president of corporate administration Jacob Liawatidewi and chief financial officer Bill Peters, the chat partly...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?